GIC
BIIB icon

Generali Investments CEE’s Biogen BIIB Stock Holding History

Generali Investments CEE’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.41M Hold
43,552
– – 0.45% 60
2026
Q1 		$7.98M Hold
43,552
– – 0.42% 68
2025
Q4 		$7.66M Buy
43,552
+4,797
+12% +$784K 0.54% 48
2025
Q3 		$5.43M Hold
38,755
– – 0.41% 76
2025
Q2 		$4.87M Buy
38,755
+11,695
+43% +$1.46M 0.4% 76
2025
Q1 		$3.7M Hold
27,060
– – 0.35% 99
2024
Q4 		$4.14M Buy
+27,060
New +$4.56M 0.43% 72

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Investments CEE's BIIB Position: Q2 2026 in Review

Generali Investments CEE held its Biogen (BIIB) position steady in Q2 2026 at 43,552 shares worth $9.41M. The position accounts for 0.45% of the portfolio, ranked #60.

Generali Investments CEE first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Generali Investments CEE held 43,552 shares of Biogen worth $9.41M as of Q2 2026.
  • Generali Investments CEE left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.45% of Generali Investments CEE's portfolio in Q2 2026, its #60 holding.
  • Generali Investments CEE first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.